To elucidate the potential role of ASPA in PCa progression, we employed gain- and loss-of-function approaches in vitro and in vivo to investigate ASPA as a suppressor of PCa progression and as a potential therapeutic target for human PCa. Here, ASPA is linked to posterior cortical atrophy.